THERAPEUTIC EFFECT ON HEART RATE: VISIBLE SIMPLICITY AND REAL DIFFICULTY

by S. R. GILYAREVSKY, M. V. GOLSHMID, I. M. KUZMINA
Published 2016-12-01

ROLE OF POWERFUL STATINS IN MODERN TREATMENT OF PATIENTS WITH A HIGH RISK OF COMPLICATIONS ARISING FROM ATHEROSCLEROSIS

by S. R. Gilyarevskijy, M. V. Golshmid, I. M. Kuzmina
Published 2017-11-01

The application of torasemide in patients with arterial hypertension: evidence-based and practical approaches

by S R Gilyarevsky, I M Kuzmina, M V Golshmid
Published 2014-12-01

The correlation of the efficacy and safety of statins with the aim of primary and secondary prevention: myths and reality

by S R Gilyarevsky, M V Golshmid, I M Kuzmina
Published 2015-06-01

INTEGRATION OF BIOMARKERS INTO THE PRACTICE OF TREATING PATIENTS WITH HEART FAILURE: THE ROLE OF DETERMINING THE BLOOD LEVEL OF NATRIURETIC PEPTIDES

by S. R. Gilyarevskiy, M. V. Golshmid, I. M. Kuzmina
Published 2017-12-01

Modern strategy of treating patients with coronary artery disease: complementarity principle in therapy and new ideas about its role and components

by S. R. Gilyarevskiy, M. V. Golshmid, I. M. Kuzmina
Published 2019-11-01

Use of pharmacoinvasive approach to the treatment of patients with ST segment elevation acute coronary syndrome: state of the problem

by S. R. Gilyarevskiy, M. V. Golshmid, I. M. Kuz'mina
Published 2015-12-01

INNOVATIVE TECHNOLOGIES IN CARDIOLOGY: FROM SURPRISE TO HABIT OR FORGETFULNESS

by S. R. Gilyarevskiy, M. V. Golshmid, I. M. Kuz'mina
Published 2015-09-01

Use of pharmacoinvasive approach to the treatment of patients with ST segment elevation acute coronary syndrome: state of the problem

by S. R. Gilyarevskiy, M. V. Golshmid, I. M. Kuz'mina
Published 2015-12-01

INNOVATIVE TECHNOLOGIES IN CARDIOLOGY: FROM SURPRISE TO HABIT OR FORGETFULNESS

by S. R. Gilyarevskiy, M. V. Golshmid, I. M. Kuz'mina
Published 2015-09-01

Not fully informed possibilities for prevention of atherosclerosis

by S. R. Gilyarevsky, M. V. Golshmid, I. M. Kuzmina, N. G. Bendiliani
Published 2018-04-01

New clinical and pharmacological aspects of the use of atorvastatin for primary and secondary prevention of complications of cardiovascular diseases

by S. R. Gilyarevsky, M. V. Golshmid, I. M. Kuzmina, I. I. Sinitsina
Published 2018-09-01

Angiotensin-converting enzyme inhibitors or sartans in patients at high risk for cardiovascular events: a wrong question or an undesirable answer

by S R Gilyarevsky, V A Orlov, I M Kuzmina, M V Golshmid
Published 2013-03-01

New Clinical Aspects of Eplerenone Use in Clinical Practice

by S. R. Gilyarevskiy, N. G. Bendeliani, M. V. Golshmid, I. M. Kuzmina
Published 2018-09-01

Anemia in Patients with Heart Failure: Current State of the Problem

by S. R. Gilyarevsky, M. V. Golshmid, I. M. Kuzmina, N. G. Bendeliani
Published 2019-04-01

SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW

by S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina
Published 2016-01-01

A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist

by S. R. Gilyarevskiy, M. V. Golshmid, G. Yu. Zaharova, I. M. Kuzmina, I. I. Sinitsina
Published 2019-05-01

SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW

by S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina
Published 2016-01-01

EVIDENCE-BASED USE OF EPLERENONE

by S. R. Gilyarevski, V. A. Orlov, I. M. Kuzmina, M. V. Golshmid, G. Y. Zakharova, I. I. Sinitsina
Published 2014-07-01

New targets and old therapies for arterial hypertension

by S. R. Gilyarevsky, N. G. Bendeliani, M. V. Golshmid, G. Yu. Zakharova, I. M. Kuzmina, I. I. Sinitsina
Published 2019-04-01